摘要
A novel class of colchicine-SAHA hybrids were designed and synthesised based on the synergistic antitumor effect of tubulin inhibitors and histone deacetylases (HDAC) inhibitors. To the best of our knowledge, this is the first design of molecules that are dual inhibitors of tubulin and HDAC. Biological evaluations of these compounds included the inhibitory activity of HDAC, in vitro cell cycle analysis in BEL-7402 cells as well as cytotoxicity in five cancer cell lines.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 3240-3244 |
| 页数 | 5 |
| 期刊 | Bioorganic and Medicinal Chemistry |
| 卷 | 21 |
| 期 | 11 |
| DOI | |
| 出版状态 | 已出版 - 1 6月 2013 |
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
指纹
探究 'The discovery of colchicine-SAHA hybrids as a new class of antitumor agents' 的科研主题。它们共同构成独一无二的指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver